İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

68 F
San Diego
Sunday, May 19, 2024
-Advertisement-

Obalon Gets $16.5M in Venture Capital

Carlsbad-based Obalon Therapeutics Inc. closed a $16.5 million series C private equity financing led by InterWest Partners of Menlo Park. Domain Associates, with headquarters in Princeton, N.J., and Okapi Venture Capital of Laguna Beach also participated.

Obalon also announced that it has secured Food and Drug Administration approval to evaluate the safety and effectiveness of the company’s nonsurgical, fully reversible device for weight loss. The device consists of a capsule containing a balloon that is swallowed and then remotely inflated. The balloon is intended to occupy space in the stomach to create a feeling of fullness to help people eat less. At the end of the treatment period, the balloon is removed.

Four clinical trials of the device have been completed outside the U.S., the company said. A 34 percent excess weight loss occurred in a three-month clinical study in Mexico, and similar results were achieved in European studies, according to the company.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-